Izotropic Corporation

About Izotropic Corporation

Izotropic Corporation is dedicated to advancing breast cancer imaging through its innovative IzoView Breast CT platform. The company aims to address gaps in traditional imaging tools, particularly for women with dense breast tissue, by offering true 3D imaging with no compression and high spatial resolution. Izotropic is focused on leading a new category in breast imaging with a commitment to earlier and more accurate cancer detection.

Products & Services

IzoView Breast CT:A dedicated Breast CT platform designed for women with dense breast tissue, providing true 3D imaging, no compression, and 100x the spatial resolution of MRI. It is built for fast, comfortable scans and is preparing for a pivotal clinical study.

Specialties

Breast CT Technology 3D Imaging Dense Breast Tissue Imaging AI in Breast Imaging Clinical Research Medical Device Commercialization

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Private Placement T: - FT: Private Placement	A: 300000 MR: - FA: up to $300,000.00 FAN: 300000	D: 2024-06-06 FD: 2024-06-06	-

Private Placement Latest

2024-06-06

$300K

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

S

Shadi Shakeri

MD, FSBI, Advisor & Clinical Consultant

J

John M. Boone

Ph.D., Principal Founder of Breast CT, Director

C

Craig Abbey

Advisor

M

Martin Yaffe

Ph.D., Member of the Order of Canada, Advisor

N

Norbert Pelc

Development and Technology Advisor

C

Craig Shimasaki

Ph.D., MBA, Medical Device Business Advisor

View 15 more team members with Pro

Unlock Full Team Directory

Recent News